GlassScriptPhysician profile
Indy W Lane
NPI 1457374258
$1,775.48
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $83.77 · 2022: $242 · 2023: $533 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $583.61 | 2019-2020 | |
| Hologic Sales and Service, LLC | $160.19 | 2019-2023 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Abbvie INC. | $142.80 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $117.36 | 2022-2023 | |
| Astellas Pharma US INC | $96.21 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $95.09 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $93.91 | 2019-2023 | Endosee, Paragard T 380a |
| Exeltis, USA INC. | $88.73 | 2020-2024 | Slynd |
| Lupin INC. | $81.78 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.91 | 2022-2024 | |
| Pfizer INC. | $39.42 | 2022-2023 | |
| Amag Pharmaceuticals, INC. | $37.74 | 2019 | |
| Duchesnay USA Incorporated | $27.65 | 2019 | |
| Shield Therapeutics INC | $26.37 | 2024 | |
| Avion Pharmaceuticals | $23.63 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $17.90 | 2023 | Nexplanon |
| Mallinckrodt Enterprises LLC | $17.45 | 2019 | |
| Therapeuticsmd, INC. | $15.85 | 2022 | |
| Merck Sharp & Dohme LLC | $13.37 | 2019 | |
| Asensus Surgical, INC. | $12.18 | 2019 | |
| Meditrina | $9.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indy Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.